Autem Therapeutics
PrivateLast Round
Series A
Extension
Jun 6, 2022
Total Funding Raised
$14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Autem Therapeutics is an oncology and bioelectric technology company developing a non-invasive, non-toxic treatment platform for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autem Therapeutics Comparables
Compare Autem Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraBionic | 86% | |
| EMulate Therapeutics | 85% | |
| LifeBridge Innovations, PBC | 84% |
Autem Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 6, 2022 |
Key People
Founding team and executive leadership
Autem Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Series A Extension |
| Spectra Investimentos | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 73% MoM.
- May 15, 2026
Monthly visitors grew 203% MoM.
Autem Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Autem Therapeutics's valuation, stock price, and market status.
Is Autem Therapeutics a public or private company?
Autem Therapeutics is a private company.
What is the current stock price of Autem Therapeutics?
Autem Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Autem Therapeutics worth (valuation)?
Valuation information for Autem Therapeutics is not publicly available.
Can I buy Autem Therapeutics stock?
Autem Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Autem Therapeutics's last funding round?
Autem Therapeutics's most recent funding round was Series A Extension on June 6, 2022.
Who are the main investors in Autem Therapeutics?
Key investors in Autem Therapeutics include Zentynel Frontier Investments.
Will Autem Therapeutics IPO soon?
No public IPO plans have been announced for Autem Therapeutics.
How can I track Autem Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Autem Therapeutics's secondary market activity and sign up for updates.